MDB-20. IMPROVING THE PERSISTENCE OF CAR T CELLS AGAINST GROUP 3 MEDULLOBLASTOMAS VIA EPIGENETIC REGULATION OF EXHAUSTION

Medulloblastomas (MB) are the most common malignant pediatric brain tumor with molecular subclass Group 3 (G3) requiring the most intense treatment regimen including surgery, intensive radiation followed by chemotherapy. Despite an overall 40% survival rate, survivors’ quality of life is often impai...

Descripción completa

Detalles Bibliográficos
Autores principales: Dukes, Meghan, Houke, Haley, Zindy, Frederique, Youngblood, Ben, Roussel, Martine, Krenciute, Giedre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Medulloblastomas - MDB
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260047/
http://dx.doi.org/10.1093/neuonc/noad073.253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260047/
http://dx.doi.org/10.1093/neuonc/noad073.253

Ejemplares similares